Title : Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand.

Pub. Date : 1995 Mar

PMID : 9383417






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rapamycin, ascomycin and FK506 have a common domain responsible for binding to FKBP12, their cellular receptor, and different effector domains that determine the target of the complex. Tacrolimus FKBP prolyl isomerase 1A pseudogene 1 Homo sapiens
2 CONCLUSIONS: The designed rapamycin-based FKBP12 ligand exhibits powerful binding properties but, unlike rapamycin, shows no activity in IL-6 dependent B-cell proliferation and, in contrast to FK506, shows no activity in the IL-2 reporter assay. Tacrolimus FKBP prolyl isomerase 1A pseudogene 1 Homo sapiens